SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters - 28/09/23
Doi : 10.1016/S1473-3099(23)00548-0
Kim Blom a, Peter Fjällström b, Christian Molnár c, Mikael Åberg d, Linnea Vikström b, Julia Wigren-Byström b, Louise Bennet e, Micael Widerström b, Gunlög Rasmussen f, Jonas Klingström g, Mattias N E Forsell b, †, Anders F Johansson b, † 
a Public Health Agency of Sweden, Sweden
b Department of Clinical Microbiology, Umeå University, Umeå, Sweden
c Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Familjeläkarna AB, Stockholm, Sweden
d Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden
e Clinical Studies Sweden, Forum South, Skåne University Hospital and Department of Clinical Sciences, Lund University, Lund, Sweden
f School of Medical Sciences, Örebro University, Örebro, Sweden
g Department of Biomedical Clinical Sciences, Linköping University, Linköping, Sweden
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
© 2023
Elsevier Ltd. Tous droits réservés.
Vol 23 - N° 10
P. e393-e394 - octobre 2023 Retour au numéro
Article précédent
- Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
- Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Alexandra Dopfer-Jablonka, Metodi V Stankov, Sebastian R Schulz, Hans-Martin Jäck, Georg M N Behrens, Stefan Pöhlmann, Markus Hoffmann
- Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5
- Yu Kaku, Yusuke Kosugi, Keiya Uriu, Jumpei Ito, Alfredo A Hinay, Jin Kuramochi, Kenji Sadamasu, Kazuhisa Yoshimura, Hiroyuki Asakura, Mami Nagashima, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato
Bienvenue sur EM-consulte, la référence des professionnels de santé.